Three notes:
1. After undergoing the minimally invasive Mild procedure, physicians will track patient’s success through the Fitbit.
2. The motion study is being conducted at 20 centers. Patients will be evaluated at six-, 12- and 24-months postoperatively.
3. Vertos Medical expects to have the results of the randomized, controlled study in a year and a half.
More articles on devices and implants:
3 things to know about Group FH Ortho
Nanovis wins Global Health & Pharma’s nanotechnology award: 3 details
Minimally invasive surgical instruments market to reach $38.3B by 2025 due to spine surgery demands
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.